FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate. The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
HR 3962, the ESTUARIES Act, extends a deadline within the National Estuary Program. It amends Section 320(i)(1) of the Federal Water Pollution Control Act by changing the year "2026" to "2031" in a requirement related to program management. This change directly affects the National Estuary Program, which oversees coastal water quality protection and restoration efforts. The bill makes a specific procedural adjustment to the program's timeline without altering its core policies or funding.
The Protect America's Workforce Act cancels an executive order issued on March 27, 2025, that excluded certain groups from federal labor-management relations programs, making it legally unenforceable. It also ensures that all collective bargaining agreements between federal agencies and labor unions, which were active as of March 26, 2025, remain fully effective until their agreed terms expire. This directly affects federal agencies, labor unions, and the employees covered by these agreements. The bill prevents federal funds from being used to implement the canceled executive order while preserving existing labor agreements.
This bill authorizes the placement of a memorial honoring women who supported the U.S. war effort during World War II (including those working as pilots, engineers, and in factories) on federal land in Washington, D.C. It specifies two locations: Area I on the National Mall map or the National Mall Reserve, as defined in existing law. The memorial was previously authorized by Section 702 of the 2023 Consolidated Appropriations Act (Public Law 117-328), and this bill clarifies its permitted locations.
SRES 483 is a ceremonial Senate resolution honoring Dr. Jane Goodall, who passed away on October 1, 2025. It pays tribute to her lifelong work as a primatologist, conservationist, and founder of the Jane Goodall Institute and Roots & Shoots program, which engages youth globally in environmental action. The resolution recognizes her scientific contributions - including groundbreaking chimpanzee research at Gombe - and her advocacy for wildlife protection, education, and community-based conservation efforts like Tanzania's TACARE program. As a non-binding resolution, it does not enact policy changes but formally commemorates her legacy.
This bill directs the American Battle Monuments Commission to correct historical errors by identifying Jewish World War I and II veterans buried overseas under incorrect Christian markers (Latin crosses) and replacing them with appropriate markers. It establishes a 10-year program to contact families of affected veterans, with the Commission funding the effort at $500,000 annually through nonprofit contracts. The program specifically targets veterans buried in foreign U.S. military cemeteries with markers indicating non-Jewish faith, addressing a documented mistake affecting approximately 900 Jewish servicemembers. This directly affects Jewish veterans' families by honoring their heritage and correcting past burial inaccuracies.
This bill (HR 249) renames two specific facilities at Paterson Great Falls National Historical Park in honor of the late Congressman Bill Pascrell, Jr. The Great Falls Scenic Overlook Trail Bridge will be called "Bill Pascrell, Jr. Scenic Overlook Trail Bridge," and Overlook Park will be called "Bill Pascrell, Jr. Overlook Park." All federal references in laws, maps, documents, or records will automatically update to reflect these new names. As a procedural naming bill, it has no policy or funding impact beyond the official renaming of park features.
SRES 536 is a non-binding Senate resolution designating December 2, 2025, as "World Nuclear Energy Day." It commemorates nuclear energy's role in clean power generation, highlighting historical milestones like the first nuclear chain reaction (1942) and the first commercial nuclear plant (1957). The resolution celebrates nuclear energy's contributions to U.S. electricity (18% of generation, 43% carbon-free), job creation (over 70,000 direct jobs), and national security, without creating new laws or affecting any group. It serves as a symbolic recognition of the industry's achievements.
SRES 531 is a non-binding Senate resolution celebrating the 50th anniversary of the Individuals with Disabilities Education Act (IDEA) on November 29, 2025. It recognizes IDEA's historical role in guaranteeing children with disabilities access to free appropriate public education in inclusive settings, transforming educational opportunities for millions. The resolution honors students, families, educators, and advocates who advanced IDEA's principles since its 1975 enactment. It does not create new policy but formally acknowledges the law's enduring impact on educational equity.
SBA Fraud Enforcement Extension Act This bill extends the statute of limitations to 10 years for fraud-based criminal and civil offenses with respect to the Shuttered Venue Operators Grant and the Restaurant Revitalization Fund COVID-19 relief programs.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
HCONRES 58 is a symbolic congressional resolution denouncing socialism in all its forms. It does not create new laws or affect any policies, as it is a non-binding statement of opinion. The resolution cites historical events and quotes from Founding Fathers to argue that socialism leads to authoritarianism and economic harm, referencing examples like the Soviet Union and Venezuela. It formally "denounces" socialism and opposes implementing socialist policies in the U.S., but has no legal effect on citizens or government actions. This is a procedural resolution, not a policy measure.
